Skye Bioscience, Inc. (SKYE)
1.00
-0.04
(-3.85%)
USD |
NASDAQ |
Nov 06, 10:07
Skye Bioscience Market Cap : 4.393M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 4.569M |
| November 04, 2026 | 5.008M |
| November 03, 2026 | 5.360M |
| November 02, 2026 | 5.799M |
| October 30, 2026 | 5.623M |
| October 29, 2026 | 5.755M |
| October 28, 2026 | 6.677M |
| October 27, 2026 | 6.370M |
| October 26, 2026 | 6.897M |
| October 23, 2026 | 6.765M |
| October 22, 2026 | 7.117M |
| October 21, 2026 | 7.161M |
| October 20, 2026 | 7.117M |
| October 19, 2026 | 6.721M |
| October 16, 2026 | 6.809M |
| October 15, 2026 | 6.985M |
| October 14, 2026 | 6.897M |
| October 13, 2026 | 6.721M |
| October 12, 2026 | 6.941M |
| October 09, 2026 | 7.424M |
| October 08, 2026 | 7.380M |
| October 07, 2026 | 7.248M |
| October 06, 2026 | 7.117M |
| October 05, 2026 | 7.600M |
| October 02, 2026 | 7.380M |
| Date | Value |
|---|---|
| October 01, 2026 | 7.029M |
| September 30, 2026 | 7.073M |
| September 29, 2026 | 6.985M |
| September 28, 2026 | 7.073M |
| September 25, 2026 | 7.336M |
| September 24, 2026 | 7.468M |
| September 23, 2026 | 7.907M |
| September 22, 2026 | 7.512M |
| September 21, 2026 | 7.820M |
| September 18, 2026 | 7.754M |
| September 17, 2026 | 6.897M |
| September 16, 2026 | 7.468M |
| September 15, 2026 | 9.269M |
| September 14, 2026 | 8.742M |
| September 11, 2026 | 8.962M |
| September 10, 2026 | 9.137M |
| September 09, 2026 | 9.796M |
| September 08, 2026 | 8.259M |
| September 04, 2026 | 8.171M |
| September 03, 2026 | 7.820M |
| September 02, 2026 | 8.083M |
| September 01, 2026 | 7.907M |
| August 31, 2026 | 7.380M |
| August 28, 2026 | 7.798M |
| August 27, 2026 | 8.566M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.603B |
| Alnylam Pharmaceuticals, Inc. | 21.07B |
| Anika Therapeutics, Inc. | 224.83M |
| Savara, Inc. | 942.78M |
| Vericel Corp. | 2.633B |
Market Cap Related Metrics
| PEG Ratio | -0.0052 |
| Price | 1.00 |
| Earnings Yield | -1.02K% |
| PEGY Ratio | -0.0052 |